SC
ABBV icon

Syon Capital’s AbbVie ABBV Stock Holding History

Syon Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.62M Sell
25,838
-79
-0.3% -$17.5K 0.28% 54
2025
Q4 		$5.92M Buy
25,917
+1,078
+4% +$246K 0.3% 53
2025
Q3 		$5.75M Buy
24,839
+3,491
+16% +$711K 0.31% 53
2025
Q2 		$3.96M Sell
21,348
-1,377
-6% -$256K 0.26% 64
2025
Q1 		$4.76M Buy
22,725
+1,680
+8% +$327K 0.39% 53
2024
Q4 		$3.74M Buy
21,045
+3,371
+19% +$620K 0.34% 57
2024
Q3 		$3.49M Buy
17,674
+474
+3% +$88.5K 0.31% 57
2024
Q2 		$2.95M Sell
17,200
-749
-4% -$124K 0.27% 62
2024
Q1 		$3.27M Sell
17,949
-14,719
-45% -$2.54M 0.31% 59
2023
Q4 		$5.06M Buy
32,668
+21,296
+187% +$3.1M 0.21% 72
2023
Q3 		$1.7M Buy
+11,372
New +$1.67M 0.21% 70

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Syon Capital's ABBV Position: Q1 2026 in Review

Syon Capital reduced its AbbVie (ABBV) stake by 0.3% in Q1 2026, selling an estimated $17.5K and leaving 25,838 shares worth $5.62M. The position accounts for 0.28% of the portfolio, ranked #54.

Syon Capital first reported a position in ABBV in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.92M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Syon Capital held 25,838 shares of AbbVie worth $5.62M as of Q1 2026.
  • Syon Capital sold 79 AbbVie shares in Q1 2026, an estimated $17.5K.
  • AbbVie made up 0.28% of Syon Capital's portfolio in Q1 2026, its #54 holding.
  • Syon Capital first reported a position in AbbVie in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's AbbVie position peaked at $5.92M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.